Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6atac small nuclear 24, pseudogene (RNU6ATAC24P)
- Target
- RNU6ATAC24P
- Molecular classification
- Other (Pseudogene), Non-coding RNA locus
01
Overview
RNA, U6atac small nuclear 24, pseudogene (RNU6ATAC24P) is the genomic remnant of the U6atac small nuclear RNA, which normally acts as a structural and catalytic RNA within the minor spliceosome complex for mRNA splicing in eukaryotic cells[5]. Unlike its functional counterpart, RNU6ATAC24P does not encode a functional snRNA molecule due to disabling mutations or truncations and is classified as a pseudogene. Pseudogenes like RNU6ATAC24P are non-coding, have no protein product, and are not considered druggable targets for therapeutics. They are mainly used as markers for retrotransposition dynamics and genomic rearrangement events, without established roles in disease or cellular processes[5]. No evidence suggests this entry is a misnomer or a misspelling; rather, its non-target status derives from its pseudogene classification.
- Other names
- RNU6ATAC24PRNA, U6atac small nuclear 24, pseudogene
02
Mechanism of action
None (No mechanism of drug action applies)
03
Biological functions
None (as a pseudogene, it does not perform known biological functions)
04
Disease associations
Other (Pseudogenes sometimes serve as markers of retrotransposition dynamics, but RNU6ATAC24P does not have a documented role in disease[5].)
05
Safety considerations
None (Not therapeutically relevant)
06
Interacting drugs
None (No drugs known to interact with this pseudogene)
07
Biomarkers
None (No established biomarker role)
Beyond the preview
Go deeper on RNA, U6atac small nuclear 24, pseudogene (RNU6ATAC24P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6atac small nuclear 24, pseudogene (RNU6ATAC24P).